Literature DB >> 22098167

Audiovisual distraction reduces pain perception during shockwave lithotripsy.

Emma Marsdin1, Jeremy G Noble, John M Reynard, Benjamin W Turney.   

Abstract

BACKGROUND AND
PURPOSE: Lithotripsy is an established method to fragment kidney stones that can be performed without general anesthesia in the outpatient setting. Discomfort and/or noise, however, may deter some patients. It has been demonstrated that audiovisual distraction (AV) can reduce sedoanalgesic requirements and improve patient satisfaction in nonurologic settings, but to our knowledge, this has not been investigated with lithotripsy. This randomized controlled trial was designed to test the hypothesis that AV distraction can reduce perceived pain during lithotripsy. PATIENTS AND METHODS: All patients in the study received identical analgesia before a complete session of lithotripsy on a fixed-site Storz Modulith SLX F2 lithotripter. Patients were randomized to two groups: One group (n=61) received AV distraction via a wall-mounted 32″ (82 cm) television with wireless headphones; the other group (n=57) received no AV distraction. The mean intensity of treatment was comparable in both groups. Patients used a visual analogue scale (0-10) to record independent pain and distress scores and a nonverbal pain score was documented by the radiographer during the procedure (0-4).
RESULTS: In the group that received AV distraction, all measures of pain perception were statistically lower. The patient-reported pain score was reduced from a mean of 6.1 to 2.4 (P<0.0001), and the distress score was reduced from a mean of 4.4 to 1.0 (P=0.0001). The mean nonverbal score recorded by the radiographer was reduced from 1.5 to 0.5 (<0.0001).
CONCLUSIONS: AV distraction significantly lowered patients' reported pain and distress scores. This correlated with the nonverbal scores reported by the radiographer. We conclude that AV distraction is a simple method of improving acceptance of lithotripsy and optimizing treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22098167     DOI: 10.1089/end.2011.0430

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  Quantification of the Range of Motion of Kidney and Ureteral Stones During Shockwave Lithotripsy in Conscious Patients.

Authors:  Suzanne R Harrogate; L M Shirley Yick; James C Williams; Robin O Cleveland; Benjamin W Turney
Journal:  J Endourol       Date:  2016-04-01       Impact factor: 2.942

2.  Efficacy of the lithotripsy in treating lower pole renal stones.

Authors:  Helen Cui; Eeke Thomee; Jeremy G Noble; John M Reynard; Benjamin W Turney
Journal:  Urolithiasis       Date:  2013-03-03       Impact factor: 3.436

3.  Obtaining patient feedback in an outpatient lithotripsy service is facilitated by use of a touch-screen tablet (iPad™) survey.

Authors:  B W Turney; J M Reynard
Journal:  Urolithiasis       Date:  2014-04-19       Impact factor: 3.436

4.  Prospective Randomized Controlled Trial to Evaluate the Effectiveness of Watching Movies to Decrease Anxiety During Extracorporeal Shock Wave Lithotripsy.

Authors:  Chinnakhet Ketsuwan; Charoen Leenanupunth; Yada Phengsalae; Premsant Sangkum; Wisoot Kongchareonsombat; Nongnart Kaewjai; Phanida Timjapoe
Journal:  Res Rep Urol       Date:  2021-02-25

5.  Effect of media distraction (audio-visual and music) for pain and anxiety control in patients undergoing shock-wave lithotripsy: A systematic review and meta-analysis.

Authors:  Weihua Hu; Ke Yang; Li Zhang; Xu Lu
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

6.  Audiovisual distraction reduces pain perception during aural microsuction.

Authors:  N Choudhury; I Amer; M Daniels; M J Wareing
Journal:  Ann R Coll Surg Engl       Date:  2013-01       Impact factor: 1.891

7.  The Effect of Rhythmic Breathing on the Severity of Sternotomy Pain after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Clinical Trial.

Authors:  Hassan Babamohamadi; Masoumeh Karkeabadi; Abbasali Ebrahimian
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.